Biotechnology, Pharmaceuticals, and Innovation by Ligand

  • Jose Antonio Gastelum
  • 10.06.2026
Ligand Pharmaceuticals stock gains 2.33% as annual Investor Day event set for December, Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals will host its annual Investor Day in New York City on December 8, the company said. Senior management, led by CEO Todd Davis, will lead the event.Ligand Pharmaceuticals' ...
  • Andreas Kristo
  • 19.12.2025
Ligand Pharmaceuticals backs Athira Pharmas $90 million funding round
Ligand Pharmaceuticals is making significant financial strides by supporting Athira Pharma through a $90 million private placement financing round. This move aims to bolster the development of ...